2022
DOI: 10.3389/fped.2022.985707
|View full text |Cite
|
Sign up to set email alerts
|

Congenital tuberculosis in a neonate following in vitro fertilization-embryo transfer: A case report

Abstract: BackgroundCongenital tuberculosis is becoming increasingly common, but congenital tuberculosis infection in neonates following in vitro fertilization and embryo transfer (IVF-ET) has been rarely reported; a diagnosis of congenital tuberculosis is often delayed due to the non-specificity of maternal IVF treatments and clinical manifestations during pregnancy—particularly in low-birth-weight preterm infants.Case presentationWe herein report a case of congenital tuberculosis. The infant was born at 27+5 weeks of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…Changes in women's immune systems during pregnancy would make them more susceptible to active TB, and delayed or missed diagnosis of TB in women undergoing active ART treatment can be potentially life threatening for the mother and devastating for conceived pregnancies [12]. Systemic hematogenous dissemination of TB after oocyte pick-up, transplacental fetal transmission of TB, and adverse maternal and neonatal outcomes such as preterm birth, miscarriage, and maternal and infant death have been reported [37,38,[48][49][50][51][52][53][54]. Therefore, the Swedish national guidelines recommend that pregnant women, especially those in high-risk areas, should be screened for TB systematically, which is helpful for early detection and treatment of LTBI and asymptomatic active TB [55].…”
Section: Discussionmentioning
confidence: 99%
“…Changes in women's immune systems during pregnancy would make them more susceptible to active TB, and delayed or missed diagnosis of TB in women undergoing active ART treatment can be potentially life threatening for the mother and devastating for conceived pregnancies [12]. Systemic hematogenous dissemination of TB after oocyte pick-up, transplacental fetal transmission of TB, and adverse maternal and neonatal outcomes such as preterm birth, miscarriage, and maternal and infant death have been reported [37,38,[48][49][50][51][52][53][54]. Therefore, the Swedish national guidelines recommend that pregnant women, especially those in high-risk areas, should be screened for TB systematically, which is helpful for early detection and treatment of LTBI and asymptomatic active TB [55].…”
Section: Discussionmentioning
confidence: 99%
“…]. Furthermore, additive concerns re-heightened by reports of transplacental fetal transmission with consequences that have ranged from late miscarriage to preterm birth to cases of congenital TB [14][15][16].…”
Section: Andandmentioning
confidence: 99%
“…Systemic hematogenous dissemination of maternal TB infection following attempts at transvaginal oocyte retrieval have been described [12 ▪ ,13 ▪▪ ]. Furthermore, additive concerns re-heightened by reports of transplacental fetal transmission with consequences that have ranged from late miscarriage to preterm birth to cases of congenital TB [14–16].…”
Section: In-vitro Fertilization In Undiagnosed and Untreated Female G...mentioning
confidence: 99%